1. AstraZeneca offloads Crestor to refocus on oncology program — Here's why JNJ is still in the coronavirus vaccine race — Pfizer/BioNTech's COVID vaccine could be approved in Europe by end of year — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

What ever happened to Ricky and Wujey?

Discussion in 'Andrx Laboratories' started by Anonymous, Jul 28, 2005 at 9:36 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Mr. Greg Wujek Appointed As President And CEO of PhytoMedical.
    Over 20 years of management, marketing and sales experience in pharmaceutical and healthcare; previously with Forest Labs, Savient Pharmaceuticals and Andrx Labs, recently acquired for $1.9 billion.

    Princeton, NJ – April 3, 2006 – PhytoMedical Technologies, Inc. (OTCBB: PYTO) (FWB: ET6) today announced the appointment of Mr. Greg Wujek as its President and Chief Executive Officer, succeeding Mr. Harmel S. Rayat; Mr. Rayat continues to serve the Company as its Chief Financial Officer and Principal Accounting Officer and as a Director. Mr. Wujek was also appointed to the Company’s Board of Directors.

    Commenting on the appointment of Mr. Wujek, Mr. Harmel S. Rayat stated, “We’re extremely pleased to have someone as experienced and talented as Greg take the helm of PhytoMedical at such an exciting time. I can’t think of anyone better suited to coordinate our Company’s ongoing research programs with our collaborating scientists, and to advance us towards PhytoMedical’s ultimate goal of commercializing our lead compounds for diabetes, Alzheimer’s disease, and cachexia.”

    Mr. Wujek brings a comprehensive, pharmaceutical-centric background to PhytoMedical, solidly grounded in business development, project management, marketing, and sales. His most recent tenure was at Savient Pharmaceuticals, where he held the position of Vice President, Sales, and was responsible for sales, operations, training, and managed care.

    Prior to joining Savient, Mr. Wujek was part of the initial team responsible for building the brand division at Andrx Laboratories. Andrx was recently acquired by Watson Pharmaceuticals for $1.9 billion. During his tenure at Andrx Laboratories, Mr. Wujek managed a team of over 450 individuals, and held several positions, including Vice President of Business Development, Vice President of Sales, as well as Vice President of Managed Care.

    Mr. Wujek has also held several senior management positions at Forest Laboratories, an international pharmaceutical company with 5,000 employees and over $3 billion in revenues.

    “I am excited and enthusiastic about the potential of our lead compounds and overwhelmed with the opportunity to work with a team of such accomplished scientists and researchers. Additionally, I look forward to working with the Company’s Board of Directors and management team, especially Mr. Rayat, in outlining our preclinical strategy and execution timeline,” comments Mr. Wujek.

    Mr. Wujek will preside over PhytoMedical’s business development and research activities from a newly opened office located in Princeton, New Jersey.

  2. Anonymous

    Anonymous Guest

    Wujey was an OK guy, he had to be micro managed by Scott Lodin, a freaking lawyer! So he did the best he could and was on a short leash by folks who had little to no pharma brand experience. I gave him the benefit of the doubt. Andrx is a classic example of a company run by lawyers to line their own jooooo pockets.
  3. Anonymous

    Anonymous Guest

    Remember Goldfarb and Loobin? Both teappot lids and ran the business into the terlet. Cohen put his croonies in charge and went off to play hockey team owner. The old division that sold cough medicine ripped off Andrx big time, the owner (some Ole Miss College football player) used to charge his indoor football team expenses to Andrx. Supprised the SEC did not put Goldfarb and his crew in jail for insider trading.